Recruiting
Bipolar disorder
RecruitingRegistered drug
A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder
Registered drug
Countries:
Denmark
Denmark- Participants:18–64 years
- Substances:Melatonin
Find therapies in clinical trials near you
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
16 trials match your criteria
Recruiting
Bipolar disorder
RecruitingRegistered drugNo placebo
Esketamine Nasal Spray for Patients with Treatment-Resistant Bipolar Depression
Registered drugNo placebo
- Substances:Esketamine
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Esketamine
Recruiting
Bipolar disorder
RecruitingRegistered drug
Study on the Effects of Low-Dose Acetylsalicylic Acid in Patients with Bipolar Disorder
Registered drug
- Substances:Acetylsalicylic Acid
Countries:
Poland
Poland- Participants:18–64 years
- Substances:Acetylsalicylic Acid
Recruiting
Bipolar disorder
RecruitingRegistered drugNo placebo
Study Comparing Lithium and Cariprazine for Treating Bipolar Depression in Patients with Bipolar Type 1 or 2 During a Depressive Episode
Registered drugNo placebo
- Substances:Cariprazine
Countries:Denmark
Denmark- Participants:18–64 years
- Substances:Cariprazine
Recruiting
Bipolar disorder
RecruitingRegistered drugNo placebo
Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II
Registered drugNo placebo
- Substances:LamotrigineLithium Carbonate
Countries:Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Lamotrigine
Recruiting
Bipolar disorder
RecruitingRegistered drugNo placebo
Study on the Effect of Citalopram, Sertraline, and Lithium for Patients with Bipolar Depression After First-Line Treatment Failure
Registered drugNo placebo
- Substances:CitalopramQuetiapine+4
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Citalopram
Recruiting
Bipolar disorder
RecruitingInvestigationalNo placebo
A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness
InvestigationalNo placebo
Countries:
Sweden
Sweden- Participants:18–64 years · 65+ years
- Substances:3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
Not yet recruiting
Bipolar disorder
Not yet recruitingRegistered drug
Effect of Adjunctive Pramipexole on Anhedonia in Adults with Bipolar Depression – Randomized, Double‑Blind, Placebo‑Controlled Phase III Trial
Registered drug
- Substances:Pramipexole
Countries:Sweden
Sweden- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Pramipexole
Not yet recruiting
Bipolar disorder+1
Not yet recruitingRegistered drug
Study on Vitamin D for Patients with Depression or Bipolar Disorder
Registered drug
- Substances:Colecalciferol
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Colecalciferol
Not yet recruiting
Bipolar disorder+2
Not yet recruitingRegistered drugNo placebo
Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure
Registered drugNo placebo
- Substances:ClozapineDuloxetine+11
Countries:Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Clozapine
Not recruiting
Bipolar disorder+1
Not recruitingRegistered drug
Study on the Effects of Etifoxine in Treating Depression in Patients with Unipolar or Bipolar Disorder
Registered drug
- Substances:Etifoxine Hydrochloride
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Etifoxine Hydrochloride
Not recruiting
Bipolar disorder
Not recruitingRegistered drug
Study on Amiloride for Treating Nephrogenic Diabetes Insipidus in Bipolar Disorder Patients on Long-term Lithium Therapy
Registered drug
- Substances:Amiloride
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Amiloride